TORONTO, Nov. 27, 2012 /CNW/ - Bayer HealthCare today announced that the results of two pivotal Phase III studies for regorafenib were published online in the journal The Lancet ahead of a future ...
The Lancet has published clinical trial data for aflibercept 8 mg (Eylea 8 mg) from the pivotal phase III PULSAR study in neovascular (wet) age-related macular degeneration (nAMD) and phase II/III ...
As well as its range of blood test meters including the Contour NEXT, Contour NEXT Link, and Contour NEXT USB , Ascensia Diabetes Care’s Microlet 2 lancing device is a neat way to get that little drop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results